Consequently, thrombolysis using recombinant tissue plasminogen activator (rt-PA) is an established therapy during the first 4.5 h after stroke onset but efficacy is only moderate at best and about 90% of all stroke patients must be excluded from rt-PA treatment due to numerous contraindications [2], [3]. Here, PLAT is linked to Stroke.